Self-mutilation and pharmacotherapy
Abstract
Objective: To critically review clinical reports on the pharmacotherapy of self-mutilation.
Methods: PubMed search and review of articles dating back to 1950 contributing to the understanding of self-mutilation and its treatment, with a special focus on pharmacotherapy. Key word searches include self-mutilation, deliberate self-harm, and pharmacotherapy of borderline personality disorder.
Results: Clinical reports specifically demonstrating reductions in self-mutilation mainly consist of open studies and case reports. These reports support the use of SSRIs, naltrexone, atypical antipsychotics, mood stabilizers, and clonidine in the treatment of self-mutilation. Better constructed studies demonstrate general reductions in impulsive aggression, often in the context of borderline personality disorder, through treatment with antidepressants, antipsychotics, and mood stabilizers.
Conclusion: There is evidence, albeit limited, for the pharmacologic management of self-mutilation. Further studies, especially double-blind, placebo-controlled trials, are needed to substantiate these preliminary findings.
References
-
- Suyemoto KL. The functions of self-mutilation. Clin Psychology Rev. 1998;18:531–54. - PubMed
-
- Green CA, Knysz III W, Tsuang MT. A homeless person with bipolar disorder and a history of serious self-mutilation. Am J Psychiatry. 2000;157:1392–7. - PubMed
-
- Fong T. Self-mutilation: Impulsive traits suggest new drug therapies. Current Psychiatry Online. 2003;2(2):1–8.
-
- Favazza AR. Bodies Under Siege: Self-Mutilation and Body Modification in Culture and Psychiatry. Second Edition. Baltimore: Johns Hopkins University Press; 1996.
-
- Nixon MK, Cloutier P, Aggarwal S. Affect regulation and addictive aspects of repetitive self-injury in hospitalized adolescents. J Am Acad Child Adolesc Psychiatry. 2002;41:1333–41. - PubMed
LinkOut - more resources
Full Text Sources
Medical